MiRus Acquires 50,000 SQFT Manufacturing Facility

ATLANTA: Following the 510(k) clearance by FDA in March 2019 of MoRe, a proprietary molybdenum rhenium superalloy for medical implants, MiRus is excited to announce a major expansion of its manufacturing capacity with the addition of a fully operational 50,000 sqft orthopaedic and spine manufacturing plant in Marietta, GA. This adds to MiRus' current 20,000 sqft manufacturing facility.

MoRe superalloy approval has been greeted with great interest by surgeons, hospitals and commercial distribution channels stated Jay Yadav, MD, Founder and CEO of MiRus. To address the exploding demand for our implants, as well as the inherent capacity and lead time issues in the current medical device market, we are dramatically expanding our manufacturing capacity in Atlanta.

MiRus is partnering with several leading surgeons and hospital systems to develop and launch innovative products on its roadmap in implants, robotics, navigation and analytics. With a view to developing market leading products to meet clinical needs in deformity, lateral, and upper extremity, we are looking to add the best implant design engineers and manufacturing engineers added Dr. Yadav.
(PRN | 11 months ago)

Like This Article?
MiRus Acquires 50,000 SQFT Manufacturing Facility